Vaccine effectiveness against SARS-CoV-2 reinfection during periods with different dominant SARS-CoV-2 variants - News-Medical.Net

A new study found that despite a lower COVID-19 vaccine efficacy against reinfection with the Omicron variant, these vaccines demonstrate a marked efficacy against reinfection with SARS-CoV-2 Alpha and Delta variants, as well as the Omicron variant.

A new study posted on the medRxiv* preprint server found that despite a lower coronavirus disease 2019 (COVID-19) vaccine efficacy against reinfection with the Omicron variant, these vaccines demonst… [+4396 chars]

full article...